Danaher Schedules Third Quarter 2022 Earnings Conference Call
WASHINGTON, Sept. 20, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2022 on Thursday, October 20, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more
GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease
Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary endpoint, demonstrating higher diagnostic efficacy for [18F]flurpiridaz PET compared to SPECT Myocardial Perfusion Imaging (MPI) With a half-life roughly 12 times longer than currently approved cardiac PET radiotracers, if approved,... Read more
GE Announces Board of Directors for Future Independent GE HealthCare; Confirms Target Spin-Off Timing of First Week of January 2023
GE HealthCare on track toward future as a standalone public company leading precision health innovation • Board members bring strong mix of expertise, industry experience and diverse perspectives to help GE HealthCare lead a new era of more precise, connected, and compassionate care• Tax free spin-off expected to be completed first week of January 2023• GE... Read more
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 2022 Global Healthcare Conference on Monday, September 12, 2022, at 9:55 a.m. (EDT). You can access the webcast of the presentation via the... Read more